Top Big-Cap Stocks to Buy-
Target Price: Rs 950
Cipla’s business in India significantly outperformed market growth in FY 21 led by its COVID-19 drug portfolio. Brokerage firms are seeing a 13.31 percent rise in share price, as it believes that One-India’s strategy for the company will continue to drive synergies and market-hit growth across its three business sectors of Prescription, Commercial Pharmaceutical and Consumer Healthcare. Moreover, the Revlimid patent settlement for a possible year launch in the second half of FY 23 provides additional growth visibility.
Target Price: Rs 580
A 7 percent rally would be required to reach the target price of Rs 580 per lot pegged by the brokerage firm. The potential recovery of the private bank in profitability, the strong increase in value from the insurance, asset management, brokerage and stable management team, IIFL Securities believes that ICICI Bank shares are likely to continue the reclassification.
Target Price: Rs 1,480
Hoping for strong earnings in the October-December quarter, IT stocks are charting an upward path. Infosys share price reached a new 52-week high of 1,381.25 rupees a share in today’s strong trading. The local brokerage firm believes the shares have another potential to rise by as much as 13 per cent from the previous close. He noted that Infosys is well positioned to gain a share of the portfolio within customers, led by its automation-led cloud offerings and efficiency solutions, which are further strengthened by an institutional large deals team with a focus on higher profit rates. “We believe Infosys will outperform TCS On revenue growth of 500 basis points + in FY 21, after a gap of 300 basis points in the past year as well.
Subsidiary Body for Implementation life insurance
Target Price: Rs 1060
And because of the attractive valuations, SBI Life Insurance’s share price may rise by 13.4 percent. IIFL Securities notes that the company is showing greater resilience against overall pressures versus its peers, with the help of robust innovations.
Target Price: Rs 6,500
The local research firm sees a 10 percent increase in SRF’s share price. SRF is poised to achieve strong profit growth in the coming years, against the backdrop of promising opportunities in its fluorine niche business and a cyclical boom in the chiller business as end-use demand from the automotive and white goods industries recovers.
(The stock recommendations in this story are by the respective brokerage and research firm. Financial Express Online does not assume any responsibility for their investment advice. Please consult an investment advisor before investing.)